TRIM E3 Ligases and Their Role in Retroviral Life Cycle
Author Information
Author(s): Uchil Pradeep D, Quinlan Brian D, Chan Wai-Tsing, Luna Joseph M, Mothes Walther
Primary Institution: Yale University School of Medicine
Hypothesis
Several TRIM proteins may contribute to the innate immunity to retroviruses.
Conclusion
The study identifies multiple TRIM proteins that exhibit antiviral activities affecting both early and late stages of the retroviral life cycle.
Supporting Evidence
- TRIM proteins were shown to inhibit HIV entry and enhance N-MLV entry.
- Gene silencing of specific TRIM proteins affected viral release.
- TRIM11 was found to regulate the levels of TRIM5, impacting retroviral restriction.
Takeaway
Scientists studied proteins called TRIMs to see how they help fight off viruses like HIV, and found that many of them can stop the virus from entering or leaving cells.
Methodology
The study involved screening 55 TRIM proteins for their ability to interfere with retroviral entry and release in HEK293 cells.
Potential Biases
Potential bias in the selection of TRIM proteins and the experimental conditions used.
Limitations
The study primarily focused on a limited number of TRIM proteins and their effects in a specific cell line.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website